GlassScriptPhysician profile
Timothy Deskins
NPI 1366833576
$827.98
in general payments reported to CMS, 2019-2025
18 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $145 · 2023: $101 · 2024: $144 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.18 | 2021-2023 | |
| Glaxosmithkline, LLC. | $96.01 | 2022-2025 | Trelegy Ellipta |
| Amgen INC. | $75.82 | 2021-2025 | Repatha, Otezla, Repatha |
| Amarin Pharma, INC. | $72.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $70.68 | 2021-2025 | Airsupra |
| Abbvie INC. | $61.17 | 2025 | |
| Novo Nordisk INC | $58.33 | 2025 | Ozempic |
| Mylan Specialty L.P. | $38.71 | 2022-2023 | Yupelri |
| Esperion Therapeutics, INC. | $38.33 | 2021-2022 | |
| Nevro Corp. | $33.76 | 2022 | |
| Exact Sciences Corporation | $30.45 | 2024 | Cologuard Collection Kit |
| Baxter Healthcare | $20.43 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $18.02 | 2025 | Ohtuvayre |
| Sumitomo Pharma America, INC. | $17.84 | 2024 | Gemtesa |
| Dexcom, INC. | $16.36 | 2023 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.16 | 2024 | Aralast |
| Bayer Healthcare Pharmaceuticals INC. | $15.53 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.88 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Deskins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.